A Palo Alto-based firm focused on investing in digital health companies plans to raise a $150 million fund. According to documents filed with the Securities and Exchange Commission, Asset Management Ventures (AMV) is raising for its fifth fund, its largest yet.
Some of AMV’s past digital health investments include digital medicines company Proteus, diabetes digital assistant Welldoc and health data analytics company Evidation. The company has also seen some significant exits in biotechnology and software, such as with drug-developer Amgen and speech-recognition company Nuance.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
AMV was created by one of Amgen’s founders, Pitch Johnson. The firm’s current partners include Skip Fleshman, founder of flight simulator company BGI; Dr. Lou Lange, former chief of cardiology at Jewish Hospital and founder of CV Therapeutics; and Rich Simoni, founder of internet video services company Talkway Communications.
Photo credit: aurielaki, Getty Images